Advertisement
Screener

MYRIAD GENETICS, INC. (MYGN) Number of Reportable Segments

2.8 / 5 stars · 68/120 Roast Me

MYRIAD GENETICS, INC. Number of Reportable Segments

MYRIAD GENETICS, INC. (MYGN) reported Number of Reportable Segments of 1 segment for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-28.

Discontinued › Notes

us-gaap:NumberOfReportableSegments · last filed 2024-02-28

  • MYRIAD GENETICS, INC. number of reportable segments for the quarter ending 2019-09-30 was 2.00 Segment, a 0.00% change year-over-year.
  • MYRIAD GENETICS, INC. number of reportable segments for the quarter ending 2018-09-30 was 2.00 Segment, a 0.00% change year-over-year.
  • MYRIAD GENETICS, INC. number of reportable segments for the quarter ending 2017-09-30 was 2.00 Segment, a 0.00% change year-over-year.
  • MYRIAD GENETICS, INC. number of reportable segments for the quarter ending 2016-09-30 was 2.00 Segment, a 0.00% change year-over-year.
  • MYRIAD GENETICS, INC. number of reportable segments for fiscal 2020 was 2.00 Segment, a 0.00% change from fiscal 2019.
  • MYRIAD GENETICS, INC. number of reportable segments for fiscal 2019 was 2.00 Segment, a 0.00% change from fiscal 2018.
  • MYRIAD GENETICS, INC. number of reportable segments for fiscal 2018 was 2.00 Segment, a 0.00% change from fiscal 2017.
  • MYRIAD GENETICS, INC. number of reportable segments for fiscal 2017 was 2.00 Segment, a 0.00% change from fiscal 2016.

Segment

Period endNumber of Reportable Segments 3 monthNumber of Reportable Segments 6 monthNumber of Reportable Segments 9 monthNumber of Reportable Segments 12 month
2020-06-302.00 Segment
10-K · filed 2020-08-13
2020-03-312.00 Segment
10-Q · filed 2020-05-06
2019-12-312.00 Segment
10-Q · filed 2020-02-07
2019-09-302.00 Segment
10-Q · filed 2019-11-06
2019-06-302.00 Segment
10-K · filed 2019-08-13
2019-03-312.00 Segment
10-Q · filed 2019-05-08
2018-12-312.00 Segment
10-Q · filed 2019-02-06
2018-09-302.00 Segment
10-Q · filed 2018-11-07
2018-06-302.00 Segment
10-K · filed 2018-08-24
2018-03-312.00 Segment
10-Q · filed 2018-05-09
2017-12-312.00 Segment
10-Q · filed 2018-02-07
2017-09-302.00 Segment
10-Q · filed 2017-11-08
2017-06-302.00 Segment
10-K · filed 2017-08-09
2017-03-312.00 Segment
10-Q · filed 2017-05-03
2016-12-312.00 Segment
10-Q · filed 2017-02-08
2016-09-302.00 Segment
10-Q · filed 2016-11-02
2016-06-302.00 Segment
10-K · filed 2016-08-10
2016-03-312.00 Segment
10-Q · filed 2016-05-04
2015-12-312.00 Segment
10-Q · filed 2016-02-03
2015-09-302.00 Segment
10-Q · filed 2015-11-04
2015-06-302.00 Segment
10-K · filed 2015-08-12
2015-03-313.00 Segment
10-Q · filed 2015-05-06
2014-12-313.00 Segment
10-Q · filed 2015-02-04
2014-09-303.00 Segment
10-Q · filed 2014-11-05
2014-06-303.00 Segment
10-K · filed 2014-08-13
2014-03-313.00 Segment
10-Q · filed 2014-05-07
2013-12-313.00 Segment
10-Q · filed 2014-02-05
2013-09-303.00 Segment
10-Q · filed 2013-11-12
2013-06-303.00 Segment
10-K · filed 2013-08-14
2013-03-313.00 Segment
10-Q · filed 2013-05-08
2012-12-313.00 Segment
10-Q · filed 2013-02-06
2012-06-303.00 Segment
10-K · filed 2012-08-15

segment

Period endNumber of Reportable Segments 3 monthNumber of Reportable Segments 6 monthNumber of Reportable Segments 9 monthNumber of Reportable Segments 12 month
2023-12-311.00 segment
10-K · filed 2024-02-28
2022-12-311.00 segment
10-K · filed 2023-03-01
2021-12-311.00 segment
10-K · filed 2022-02-25
2021-09-302.00 segment
10-Q · filed 2021-11-04
2021-06-302.00 segment
10-Q · filed 2021-08-04
2021-03-312.00 segment
10-Q · filed 2021-05-05
2020-12-312.00 segment
10-KT · filed 2021-03-16
2020-09-302.00 segment
10-Q · filed 2020-11-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92